Smartwatches may help heart patients avoid hospital readmission

NCT ID NCT07687862

First seen Jul 07, 2026 · Last updated Jul 10, 2026 · Updated 3 times

Summary

This study tests whether wearable devices like smartwatches and ECG straps can help doctors remotely manage patients with both heart failure and atrial fibrillation. Participants use the devices to send real-time health data to their care team, who adjust medications and treatments accordingly. The goal is to see if this approach reduces the risk of death or repeat hospital stays compared to standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
wearable device-based remote management (smartwatch/ECG strap)
What this could lead to
If successful, this approach could provide a new way to monitor and treat heart failure and atrial fibrillation at home, potentially reducing hospital visits and improving survival.
What could go wrong
This is a single trial; results may not apply to all patients. Wearable data may not always be accurate, and remote management might not replace in-person care for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.